{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T02:28:59Z","timestamp":1786328939323,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05318-0","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:48:20Z","timestamp":1780620500000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative hematological parameters do not predict lesion severity or recurrence in cervical intraepithelial neoplasia: a retrospective cohort study"],"prefix":"10.1007","volume":"17","author":[{"given":"Ne\u00e7irvan \u00c7a\u011fda\u015f","family":"\u00c7altek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Yassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe","family":"Bacaks\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hale \u00d6zer","family":"\u00c7altek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Aras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi\u011fit","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lkbal Temel","family":"Y\u00fcksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"5318_CR1","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.ygyno.2020.08.025","volume":"159","author":"G BOGANI","year":"2020","unstructured":"BOGANI G, DI DONATO V, SOPRACORDEVOLE F, CIAVATTINI A, GHELARDI A, LOPEZ S, et al. Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study. Gynecol Oncol. 2020;159:636\u201341. https:\/\/doi.org\/10.1016\/j.ygyno.2020.08.025.","journal-title":"Gynecol Oncol"},{"key":"5318_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ajog.2019.09.039","volume":"222","author":"H Sahlgren","year":"2020","unstructured":"Sahlgren H, Elfstr\u00f6m KM, Lamin H, Carlsten-Thor A, Eklund C, Dillner J, et al. Colposcopic and histopathologic evaluation of women with HPV persistence exiting an organized screening program. Am J Obstet Gynecol. 2020;222:253. https:\/\/doi.org\/10.1016\/j.ajog.2019.09.039.","journal-title":"Am J Obstet Gynecol"},{"key":"5318_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/J.SXMR.2019.09.005","volume":"8","author":"SL Bedell","year":"2020","unstructured":"Bedell SL, Goldstein LS, Goldstein AR, Goldstein AT. Cervical Cancer Screening: Past, Present, and Future. Sex Med Rev. 2020;8:28\u201337. https:\/\/doi.org\/10.1016\/J.SXMR.2019.09.005.","journal-title":"Sex Med Rev"},{"key":"5318_CR4","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1097\/AOG.0000000000000287","volume":"123","author":"MJ Khan","year":"2014","unstructured":"Khan MJ, Smith-Mccune KK. Treatment of cervical precancers: back to basics. Obstet Gynecol. 2014;123:1339\u201343. https:\/\/doi.org\/10.1097\/AOG.0000000000000287.","journal-title":"Obstet Gynecol"},{"key":"5318_CR5","doi-asserted-by":"publisher","unstructured":"Szab\u00f3 V, V\u00e1rb\u00edr\u00f3 S, Kalas N, Vida B, T\u00f3th Z, L\u0151czi L, et al. The Lymphocyte-to-Monocyte Ratio (LMR) as a Novel Biomarker for Cervical Cancer Risk Stratification in Conization Patients. J Clin Med. 2025;14. https:\/\/doi.org\/10.3390\/JCM14176057.","DOI":"10.3390\/JCM14176057"},{"key":"5318_CR6","doi-asserted-by":"publisher","unstructured":"Chen W, Dong Y, Liu L, Jia L, Meng L, Liu H, et al. Practical Model for Residual\/Recurrent Cervical Intraepithelial Lesions in Patients with Negative Margins after Cold-Knife Conization. J Clin Med. 2022;11. https:\/\/doi.org\/10.3390\/JCM11195634.","DOI":"10.3390\/JCM11195634"},{"key":"5318_CR7","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S1470-2045(17)30700-3","volume":"18","author":"M Arbyn","year":"2017","unstructured":"Arbyn M, Redman CWE, Verdoodt F, Kyrgiou M, Tzafetas M, Ghaem-Maghami S, et al. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis. Lancet Oncol. 2017;18:1665\u201379. https:\/\/doi.org\/10.1016\/S1470-2045(17)30700-3.","journal-title":"Lancet Oncol"},{"key":"5318_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1470-2045(11)70078-X","volume":"12","author":"M Kocken","year":"2011","unstructured":"Kocken M, Helmerhorst TJM, Berkhof J, Louwers JA, Nobbenhuis MAE, Bais AG, et al. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: A long-term multi-cohort study. Lancet Oncol. 2011;12:441\u201350. https:\/\/doi.org\/10.1016\/S1470-2045(11)70078-X.","journal-title":"Lancet Oncol"},{"key":"5318_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/LGT.0000000000000542","volume":"24","author":"BE Swift","year":"2020","unstructured":"Swift BE, Wang L, Jembere N, Kupets R. Risk of Recurrence After Treatment for Cervical Intraepithelial Neoplasia 3 and Adenocarcinoma In Situ of the Cervix: Recurrence of CIN 3 and AIS of Cervix. J Low Genit Tract Dis. 2020;24:252\u20138. https:\/\/doi.org\/10.1097\/LGT.0000000000000542.","journal-title":"J Low Genit Tract Dis"},{"key":"5318_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ygyno.2022.03.015","volume":"165","author":"FL Sand","year":"2022","unstructured":"Sand FL, Frederiksen K, Kjaer SK. Risk of recurrent disease following conization of cervical intraepithelial neoplasia grade 3 according to post-conization HPV status and surgical margins. Gynecol Oncol. 2022;165:472\u20137. https:\/\/doi.org\/10.1016\/j.ygyno.2022.03.015.","journal-title":"Gynecol Oncol"},{"key":"5318_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/LGT.0000000000000530","volume":"24","author":"M Demarco","year":"2020","unstructured":"Demarco M, Egemen D, Raine-Bennett TR, Cheung LC, Befano B, Poitras NE, et al. A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines. J Low Genit Tract Dis. 2020;24:144\u20137. https:\/\/doi.org\/10.1097\/LGT.0000000000000530.","journal-title":"J Low Genit Tract Dis"},{"key":"5318_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/S00404-010-1611-1","volume":"284","author":"CT Lodi","year":"2011","unstructured":"Lodi CT, Michelin MA, Lima MI, Teixeira NC, Adad SJ, Murta EF, et al. Factors associated with recurrence of cervical intraepithelial neoplasia after conization in HIV-infected and noninfected women. Arch Gynecol Obstet. 2011;284:191\u20137. https:\/\/doi.org\/10.1007\/S00404-010-1611-1.","journal-title":"Arch Gynecol Obstet"},{"key":"5318_CR13","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ajem.2019.10.023","volume":"38","author":"Z Huang","year":"2020","unstructured":"Huang Z, Fu Z, Huang W, Huang K. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysis. Am J Emerg Med. 2020;38:641\u20137. https:\/\/doi.org\/10.1016\/j.ajem.2019.10.023.","journal-title":"Am J Emerg Med"},{"key":"5318_CR14","doi-asserted-by":"publisher","unstructured":"Cupp MA, Cariolou M, Tzoulaki I, Aune D, Evangelou E, Berlanga-Taylor AJ. Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med. 2020;18. https:\/\/doi.org\/10.1186\/S12916-020-01817-1.","DOI":"10.1186\/S12916-020-01817-1"},{"key":"5318_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ygyno.2017.02.026","volume":"145","author":"JL Ethier","year":"2017","unstructured":"Ethier JL, Desautels DN, Templeton AJ, Oza A, Amir E, Lheureux S. Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis. Gynecol Oncol. 2017;145:584\u201394. https:\/\/doi.org\/10.1016\/j.ygyno.2017.02.026.","journal-title":"Gynecol Oncol"},{"key":"5318_CR16","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.7150\/IJMS.64658","volume":"18","author":"H Song","year":"2021","unstructured":"Song H, Jeong MJ, Cha J, Lee JS, Yoo JG, Song MJ, et al. Preoperative neutrophil-to-lymphocyte, platelet-to-lymphocyte and monocyte-to-lymphocyte ratio as a prognostic factor in non-endometrioid endometrial cancer. Int J Med Sci. 2021;18:3712\u20137. https:\/\/doi.org\/10.7150\/IJMS.64658.","journal-title":"Int J Med Sci"},{"key":"5318_CR17","doi-asserted-by":"publisher","unstructured":"Vida B, Keszthelyi E, T\u00f3th Z, L\u0151czi L, Seb\u0151k B, Merkely P, et al. The Neutrophil-to-Lymphocyte Ratio (NLR) as a Potential Predictor in Conization Outcomes for Cervical Cancer. Cancers (Basel). 2025;17. https:\/\/doi.org\/10.3390\/CANCERS17111856.","DOI":"10.3390\/CANCERS17111856"},{"key":"5318_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","journal-title":"J Clin Epidemiol"},{"key":"5318_CR19","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/JNCI\/DJI237","volume":"97","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM, et al. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst. 2005;97:1180\u20134. https:\/\/doi.org\/10.1093\/JNCI\/DJI237.","journal-title":"J Natl Cancer Inst"},{"key":"5318_CR20","unstructured":"Pathology Outlines - WHO classification. https:\/\/www.pathologyoutlines.com\/topic\/ovarytumorwhoclassif.html. Accessed 20 Nov 2025."},{"key":"5318_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/CAAC.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/CAAC.21834.","journal-title":"CA Cancer J Clin"},{"key":"5318_CR22","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8:e191\u2013203. https:\/\/doi.org\/10.1016\/S2214-109X(19)30482-6.","journal-title":"Lancet Glob Health"},{"key":"5318_CR23","doi-asserted-by":"publisher","unstructured":"Burmeister CA, Khan SF, Sch\u00e4fer G, Mbatani N, Adams T, Moodley J, et al. Cervical cancer therapies: Current challenges and future perspectives. Tumour Virus Res. 2022;13. https:\/\/doi.org\/10.1016\/j.tvr.2022.200238.","DOI":"10.1016\/j.tvr.2022.200238"},{"key":"5318_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ygyno.2022.09.016","volume":"167","author":"M Kiviharju","year":"2022","unstructured":"Kiviharju M, Heinonen A, Jakobsson M, Virtanen S, Auvinen E, Kotaniemi-Talonen L, et al. Overtreatment rate after immediate local excision of suspected cervical intraepithelial neoplasia: A prospective cohort study. Gynecol Oncol. 2022;167:167\u201373. https:\/\/doi.org\/10.1016\/j.ygyno.2022.09.016.","journal-title":"Gynecol Oncol"},{"key":"5318_CR25","doi-asserted-by":"publisher","unstructured":"G S, KO S, B S, Y I. The concordance between colposcopic biopsy and loop electrosurgical excision procedures in patients with known smear cytology and human papillomavirus results. North Clin Istanb. 2021;8. https:\/\/doi.org\/10.14744\/NCI.2021.80090.","DOI":"10.14744\/NCI.2021.80090"},{"key":"5318_CR26","doi-asserted-by":"publisher","first-page":"477","DOI":"10.5468\/OGS.2018.61.4.477","volume":"61","author":"Y Jung","year":"2018","unstructured":"Jung Y, Lee AR, Lee SJ, Lee YS, Park DC, Park EK. Clinical factors that affect diagnostic discrepancy between colposcopically directed biopsies and loop electrosurgical excision procedure conization of the uterine cervix. Obstet Gynecol Sci. 2018;61:477\u201388. https:\/\/doi.org\/10.5468\/OGS.2018.61.4.477.","journal-title":"Obstet Gynecol Sci"},{"key":"5318_CR27","doi-asserted-by":"publisher","unstructured":"Kim SI, Kim SJ, Suh DH, Kim K, No JH, Kim YB. Pathologic discrepancies between colposcopy-directed biopsy and loop electrosurgical excision procedure of the uterine cervix in women with cytologic high-grade squamous intraepithelial lesions. J Gynecol Oncol. 2020;31. https:\/\/doi.org\/10.3802\/JGO.2020.31.E13.","DOI":"10.3802\/JGO.2020.31.E13"},{"key":"5318_CR28","doi-asserted-by":"publisher","unstructured":"Li YX, Chang JY, He MY, Wang HR, Luo DQ, Li FH, et al. Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) Predict Clinical Outcome in Patients with Stage IIB Cervical Cancer. J Oncol. 2021;2021. https:\/\/doi.org\/10.1155\/2021\/2939162.","DOI":"10.1155\/2021\/2939162"},{"key":"5318_CR29","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.cca.2020.09.008","volume":"510","author":"H Trinh","year":"2020","unstructured":"Trinh H, Dzul SP, Hyder J, Jang H, Kim S, Flowers J, et al. Prognostic value of changes in neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR) for patients with cervical cancer undergoing definitive chemoradiotherapy (dCRT). Clin Chim Acta. 2020;510:711\u20136. https:\/\/doi.org\/10.1016\/j.cca.2020.09.008.","journal-title":"Clin Chim Acta"},{"key":"5318_CR30","doi-asserted-by":"publisher","unstructured":"Qin L, Zhang L. The predictive value of serum inflammatory markers for the severity of cervical lesions. BMC Cancer. 2024;24. https:\/\/doi.org\/10.1186\/S12885-024-12561-7.","DOI":"10.1186\/S12885-024-12561-7"},{"key":"5318_CR31","doi-asserted-by":"publisher","unstructured":"Tas M, Yavuz A, Ak M, Ozcelik B. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Discriminating Precancerous Pathologies from Cervical Cancer. J Oncol. 2019;2019. https:\/\/doi.org\/10.1155\/2019\/2476082","DOI":"10.1155\/2019\/2476082"},{"key":"5318_CR32","doi-asserted-by":"publisher","unstructured":"Lycke KD, Kahlert J, Damgaard RK, Eriksen DO, Bennetsen MH, Gravitt PE, et al. Clinical course of cervical intraepithelial neoplasia grade 2: a population-based cohort study. Am J Obstet Gynecol. 2023;229. https:\/\/doi.org\/10.1016\/j.ajog.2023.08.008. :656.e1-656.e15.","DOI":"10.1016\/j.ajog.2023.08.008"},{"key":"5318_CR33","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/S00404-025-08097-1","volume":"312","author":"U Ehlers","year":"2025","unstructured":"Ehlers U, Hoischen L, Stalp JL, Hachenberg J, Ramachandran D, Br\u00fcning B, et al. The treatment of cervical intraepithelial neoplasia grade 2 (HSIL): between active surveillance and surgery-a 10-year monocentric data analysis. Arch Gynecol Obstet. 2025;312:1125\u201332. https:\/\/doi.org\/10.1007\/S00404-025-08097-1.","journal-title":"Arch Gynecol Obstet"},{"key":"5318_CR34","doi-asserted-by":"publisher","unstructured":"Kyrgiou M, Athanasiou A, Kalliala IEJ, Paraskevaidi M, Mitra A, Martin-Hirsch PPL, et al. Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease. Cochrane Database Syst Rev. 2017;11. https:\/\/doi.org\/10.1002\/14651858.CD012847.","DOI":"10.1002\/14651858.CD012847"},{"key":"5318_CR35","doi-asserted-by":"publisher","unstructured":"Xia W, Dai X, Hu Y, Yang S, Chen C, Li X. Value of intraoperative post-conisation human papillomavirus testing in predicting residual or recurrence after treatment with a loop electrosurgical excision procedure in women with HR-HPV positive and cervical high-grade squamous intraepithelial lesion. BMC Cancer. 2024;24. https:\/\/doi.org\/10.1186\/S12885-024-13272-9.","DOI":"10.1186\/S12885-024-13272-9"},{"key":"5318_CR36","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/IJGO.14340","volume":"160","author":"T Ding","year":"2023","unstructured":"Ding T, Li L, Duan R, Chen Y, Yang B, Xi M. Risk factors analysis of recurrent disease after treatment with a loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia. Int J Gynaecol Obstet. 2023;160:538\u201347. https:\/\/doi.org\/10.1002\/IJGO.14340.","journal-title":"Int J Gynaecol Obstet"},{"key":"5318_CR37","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1182\/BLOOD-2014-08-531582","volume":"126","author":"AT Franco","year":"2015","unstructured":"Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood. 2015;126:582\u20138. https:\/\/doi.org\/10.1182\/BLOOD-2014-08-531582.","journal-title":"Blood"},{"key":"5318_CR38","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.31557\/APJCP.2019.20.8.2365","volume":"20","author":"F Farzaneh","year":"2019","unstructured":"Farzaneh F, Faghih N, Hosseini MS, Arab M, Ashrafganjoei T, Bahman A. Evaluation of Neutrophil-Lymphocyte Ratio as a Prognostic Factor in Cervical Intraepithelial Neoplasia Recurrence. Asian Pac J Cancer Prev. 2019;20:2365\u201372. https:\/\/doi.org\/10.31557\/APJCP.2019.20.8.2365.","journal-title":"Asian Pac J Cancer Prev"},{"key":"5318_CR39","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.7150\/JCA.19173","volume":"8","author":"S Chun","year":"2017","unstructured":"Chun S, Shin K, Kim KH, Kim HY, Eo W, Lee JY, et al. The Neutrophil-Lymphocyte Ratio Predicts Recurrence of Cervical Intraepithelial Neoplasia. J Cancer. 2017;8:2205\u201311. https:\/\/doi.org\/10.7150\/JCA.19173.","journal-title":"J Cancer"},{"key":"5318_CR40","doi-asserted-by":"publisher","unstructured":"Origoni M, Cantatore F, Candotti G, Candiani M. Prognostic Significance of Neutrophil\/Lymphocytes Ratio (NLR) in Predicting Recurrence of Cervical Dysplasia. Biomed Res Int. 2022;2022. https:\/\/doi.org\/10.1155\/2022\/1149789.","DOI":"10.1155\/2022\/1149789"},{"key":"5318_CR41","doi-asserted-by":"publisher","unstructured":"Martinelli C, Ercoli A, Vizzielli G, Burk SR, Cuomo M, Satasiya V, et al. Liquid biopsy in gynecological cancers: a translational framework from molecular insights to precision oncology and clinical practice. J Exp Clin Cancer Res. 2025;44. https:\/\/doi.org\/10.1186\/S13046-025-03371-1.","DOI":"10.1186\/S13046-025-03371-1"},{"key":"5318_CR42","doi-asserted-by":"publisher","unstructured":"Santoro A, Angelico G, Travaglino A, Inzani F, Arciuolo D, Valente M, et al. New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO\/ESTRO\/ESP Guidelines. Cancers (Basel). 2021;13. https:\/\/doi.org\/10.3390\/CANCERS13112623.","DOI":"10.3390\/CANCERS13112623"},{"key":"5318_CR43","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.3390\/CANCERS17152420","volume":"17","author":"C Pizzimenti","year":"2025","unstructured":"Pizzimenti C, Fiorentino V, Pepe L, Franchina M, Ruggeri C, Ercoli A, et al. Predictive Biomarkers for Immunotherapy in Endometrial Carcinoma. Cancers 2025. Page 2420. 2025;17:17:2420. https:\/\/doi.org\/10.3390\/CANCERS17152420.","journal-title":"Page 2420"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05318-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05318-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05318-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:53:26Z","timestamp":1786326806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05318-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5318"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05318-0","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"15 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the Ethics Committee of Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital (Approval number: E-96317027-514.10-267056456). Due to the retrospective nature of the study, the requirement for informed consent was waived by the ethics committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1142"}}